Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Intra-nasal vaccinationVaccine, 2008
- LC16m8: An attenuated smallpox vaccineVaccine, 2006
- Suppression of Proinflammatory Signal Transduction and Gene Expression by the DualNucleic Acid Binding Domains of the Vaccinia Virus E3L ProteinsJournal of Virology, 2006
- Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccineVaccine, 2006
- ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defenseInternational Journal of Infectious Diseases, 2004
- Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia VirusJournal of Virology, 2002
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- Role of the Vaccinia Virus E3L and K3L Gene Products in Rescue of VSV and EMCV from the Effects of IFN-αJournal of Interferon & Cytokine Research, 1998
- Evaluation of Various Virulence Tests with Low Virulence Vaccinia Virus in MiceBiologicals, 1994
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987